BCR and B-cell chronic lymphocytic leukemia: Although LYN is well-known to balance BCR signaling, LYN activation seems to be dispensable in the development of CLL, since B cell specific gain- and loss-of-function mutations of LYN showed no significant changes in CLL progression in Eμ-TCL1 mice (61, 62).